b 171 (Mefloquine 250 mg)
Pill imprint b 171 has been identified as Mefloquine hydrochloride 250 mg.
Mefloquine is used in the treatment of malaria prevention; malaria and belongs to the drug class antimalarial quinolines. There is no proven risk in humans during pregnancy. Mefloquine 250 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 250 mg
- 13.00 mm
- Elliptical / Oval
- Prescription only
|NDC Code||Manufacturer / Repackager|
|54569-5407||A-S Medication Solutions, LLC (repackager)|
|23490-5858||Palmetto State Pharmaceuticals Inc (repackager)|
|21695-0449||Rebel Distributors Corp (repackager)|
Note: Inactive ingredients may vary.
More about mefloquine
- Other brands: Lariam
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.